Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background Randomized trials provide pivotal evidence for evaluation and approval of therapies. Nonetheless, such trials are often plagued by noncompliance, especially in the form of premature discontinuation of treatment. While intent-to-treat (ITT) analysis can provide valid tests of no-effect hypotheses, some trials may make ITT analysis impossible by ceasing follow-up when patients go off assigned treatment. Furthermore, estimates based on ITT, on-treatment, or per-protocol comparisons can seriously understate harm or benefit. Purpose To show how g-estimation based on randomization status is a natural generalization of ITT null testing to estimating efficacy from trials with important discontinuation or noncompliance. Methods We contrast with an analysis of the effect of a tiotropium inhaler on the occurrence of chronic obstructive pulmonary disease (COPD) events in a six-month double-blind placebo-controlled trial of 1829 patients with good but imperfect compliance. Results The covariate-adjusted point estimates, 95% confidence limits (CL), and null P-values comparing expected COPD event times in placebo versus tiotropium patients were: ITT, 1.21, CL = 1.02, 1.43, P = 0.027; on-treatment, 1.27, CL = 1.06, 1.52, P = 0.009; per-protocol, 1.36, CL = 1.13, 1.63, P = 0.001; and g-estimation, 1.31, CL = 1.03,1.72, P = 0.027. Thus g-estimation preserved the ITT test of the null, but exhibited more uncertainty about the size of the tiotropium effect than the other methods. In particular, it allowed for a much larger potential effect than did ITT analysis, but produced a much larger null P than exhibited by per-protocol analysis. Limitations Like ITT analysis, g-estimation requires all patients be followed to the end of the trial protocol, regardless of whether they comply with the protocol. Like on-treatment and per-protocol analyses, it also requires accurate compliance information be recorded. Conclusion G-estimation should become a standard procedure for the analysis of trials with noncompliance. Software to do so is available in major packages, and the procedure is easily coded for other packages. Clinical Trials 2008; 5: 5—13. http://ctj.sagepub.com
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Causal Effects Using Instrumental Variables
Angrist, J. D., Imbens, G. W., & Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476902 · Cited by 4,230
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
An introduction to instrumental variables for epidemiologists
Greenland, S. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.722 · Cited by 1,156
Self-citationRobins, J. M., & Finkelstein, D. M. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00779.x · Cited by 877
Robins, J. M., & Tsiatis, A. A. (1991) · Communications in Statistics - Theory and Methods · doi:10.1080/03610929108830654 · Cited by 423
Cited by
A review of instrumental variable estimators for Mendelian randomization
Burgess, S., Small, D. S., & Thompson, S. G. (2017) · Statistical Methods in Medical Research · doi:10.1177/0962280215597579 · Cited by 1,764
Generalizing Evidence From Randomized Clinical Trials to Target Populations: The ACTG 320 Trial
Cole, S. R., & Stuart, E. A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq084 · Cited by 486
Sullivan, S. G., Tchetgen Tchetgen, E. J., & Cowling, B. J. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww064 · Cited by 319
Statistical methods for Mendelian randomization in genome-wide association studies: A review
Boehm, F. J., & Zhou, X. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.05.015 · Cited by 318
Sussman, J. B., & Hayward, R. A. (2010) · BMJ · doi:10.1136/bmj.c2073 · Cited by 176
Metadata
- Authors
- Greenland, S., Lanes, S., & Jara, M.
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2008-02
- Volume
- 5
- Issue
- 1
- Pages
- 5-13
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W2047240089
- Cited by
- 62
- References
- 5
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation. https://app.cochat.ai/papers/10.1177/1740774507087703
- The paper
- Greenland, S., Lanes, S., & Jara, M. (2008). Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation. Clinical Trials. https://doi.org/10.1177/1740774507087703
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.